Can CBT make a meaningful contribution in the treatment of schizophrenia, bipolar disorder and severe personality disorders? Cognitive behavioural therapy (CBT) for psychosis focuses on altering the thoughts, emotions, and behaviours

Authors Avatar

Rachel Conway                                                                                                  City University, 13/12/05

Can CBT make a meaningful contribution in the treatment of schizophrenia, bipolar disorder and severe personality disorders?

Cognitive behavioural therapy (CBT) for psychosis focuses on altering the thoughts, emotions, and behaviours of patients by teaching them skills to challenge and modify beliefs about delusions and hallucinations, to engage in experimental reality testing, and to develop better coping strategies for the management of hallucinations. The goals of these interventions are to decrease the conviction of delusional beliefs, and hence their severity, and to promote more effective coping and reductions in distress. This essay will attempt to assess the contribution of CBT to each of the disorders in turn by discussing reviews on efficacy, long term effects, compliance and cost, and then compare the outcome of CBT with alternative form of drug and therapy treatments.

Schizophrenia

Schizophrenia usually involves a dramatic disturbance in thoughts and feelings and results in behaviour that may seem odd to other people. Some people hear voices, others see things which are not there, or feel they are being persecuted. Some people only experience one episode of psychosis and some recover from schizophrenia. Over the past ten years the use of CBT for treating schizophrenia has been extensively studied. Much informative research has been conducted using the empirical approach of meta-analysis, which allows one summarizing the results of multiple studies.

Turkington, Kingdon & Chadwick (2003) found that CBT has been has been effective in treating the positive and negative symptoms of schizophrenia. They note that residual symptoms have mostly improved after adult patients received an average of 20 sessions over 9 months, but are cautious in offering CBT to treat ‘first-episode schizophrenia, acute relapse, forensic patients with psychosis or those with co-morbidity such as substance misuse, personality disorder or learning disability, nor for psychosis in adolescence and old age’ as these areas have not been adequately investigated. This shows that CBT has started to make a positive contribution to treating schizophrenia but vast amounts of research need to be conducted before its safe to use in all cases, which currently limits its contribution to treatments.

Their findings are useful for the assessment of CBT, as not all studies have commented on the difference in positive symptoms after treatment. The question of whether CBT was found to be significantly beneficial because of its own merits or merely therapist contact, still remains, a factor which could have confounded the results. The study also doesn’t inform us about the benefits of CBT compared to other therapies, which is necessary for a thorough investigation.

Rector and Beck (2001) note that the effect of CBT on the secondary aspects of schizophrenia, such as anxiety or depression has not been investigated. This is a weakness in CBT efficacy research, because affective states have been round to maintain schizophrenic symptoms and constitute a risk of relapse and suicide, Siris (1995), so effects of CBT on these states undoubtedly should be addressed. One report on this has come from  who found patient depression levels to be greatly reduced after CBT treatment.

CBT has been found to be useful not just in treating patients, but in insuring they continue with their long term medication. This was found by Kemp et al (1996, 1998). This could have a huge impact on the treatment of schizophrenia because there is a problem of low compliance with all existing treatments for schizophrenia so even if this is a side affect of CBT, it’s still useful. However it may not be economically validated to have CBT for this reason alone.

All this research is futile if CBT would be too expensive to administer on a large scale. Healey, Knapp, Astin, Beecham, Kemp, Kirov  & David (1998) found CBT to be cost effective compared to other treatments, and Kuipers and colleagues (1998) have pointed to the cost-effectiveness of CBT for schizophrenia in the context of the socialized National Health Service, all evidence supporting CBT to be a practical form of treatment. Turkington et al (2002) found to be effective in realistic community settings as well as more tightly controlled randomized trails and appear to translate to clinical practice.

A new study by Valmaggia, Van Der Gaag, Tarrier, Pijnenborg, Slooff (2005) suggests that cognitive behavioural therapy may not be as effective as previously documented in treating schizophrenia. They argue that CBT is only effective in treating the positive symptoms of schizophrenia. The initial post-treatment assessment showed that patients had improved in terms of auditory hallucinations and how aware they were of their illness, and the study documents that CBT does help while in treatment, but improvements faded after an initial 6 month period. Clearly this needs to be further investigated.

Join now!

Dickerson (2000) compared CBT with other non-specific psychology interventions in 20 studies and found the effects of CBT to be of lower significance when controlled for therapy time. Although previous research has shown CBT to be affective compared to routine care, more research is needed to compare it to other therapies.

There is now strong evidence and clinical support for the implementation of CBT as part of the standard management of patients with residual symptoms of schizophrenia. Antipsychotic drugs have undesirable side affects which may be the cause of low compliance rate (Healy et al, 1998). CBT ...

This is a preview of the whole essay